BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15923803)

  • 1. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results.
    Jatoi I; Proschan MA
    Am J Clin Oncol; 2005 Jun; 28(3):289-94. PubMed ID: 15923803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
    Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
    Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
    Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
    Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
    ; McGale P; Taylor C; Correa C; Cutter D; Duane F; Ewertz M; Gray R; Mannu G; Peto R; Whelan T; Wang Y; Wang Z; Darby S
    Lancet; 2014 Jun; 383(9935):2127-35. PubMed ID: 24656685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
    van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
    J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
    Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival.
    Morris AD; Morris RD; Wilson JF; White J; Steinberg S; Okunieff P; Arriagada R; Lê MG; Blichert-Toft M; van Dongen JA
    Cancer J Sci Am; 1997; 3(1):6-12. PubMed ID: 9072310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in breast cancer treatment and survival for women with disabilities.
    McCarthy EP; Ngo LH; Roetzheim RG; Chirikos TN; Li D; Drews RE; Iezzoni LI
    Ann Intern Med; 2006 Nov; 145(9):637-45. PubMed ID: 17088576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical contraindications are not a major factor in the underutilization of breast conserving therapy.
    Morrow M; Bucci C; Rademaker A
    J Am Coll Surg; 1998 Mar; 186(3):269-74. PubMed ID: 9510257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies.
    Wang L; Guyatt GH; Kennedy SA; Romerosa B; Kwon HY; Kaushal A; Chang Y; Craigie S; de Almeida CPB; Couban RJ; Parascandalo SR; Izhar Z; Reid S; Khan JS; McGillion M; Busse JW
    CMAJ; 2016 Oct; 188(14):E352-E361. PubMed ID: 27402075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of women after breast conserving surgery for early stage breast cancer.
    Du Xianglin ; Freeman JL; Nattinger AB; Goodwin JS
    Breast Cancer Res Treat; 2002 Mar; 72(1):23-31. PubMed ID: 12000218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.
    van der Hage JA; Putter H; Bonnema J; Bartelink H; Therasse P; van de Velde CJ;
    Eur J Cancer; 2003 Oct; 39(15):2192-9. PubMed ID: 14522378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.
    Clark RM; Whelan T; Levine M; Roberts R; Willan A; McCulloch P; Lipa M; Wilkinson RH; Mahoney LJ
    J Natl Cancer Inst; 1996 Nov; 88(22):1659-64. PubMed ID: 8931610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.